Our team | PDC*line Pharma
Team – CuraVac
Heterogeneity of Human Milk β(1 – 4)‐d‐Galactosyltransferase - PRIEELS - 1975 - European Journal of Biochemistry - Wiley Online Library
IV Edition - Vaccine immunology and preclinical research | Master Program in Vaccinology And pharmaceutical Clinical Development
Breakthrough Partnership Paves the Way for Advanced Exosome-Based Therapies----Shenzhen Institute of Advanced Technology
Jean-Paul Prieels - Chief Executive Officer - convEyXO | LinkedIn
Des Belges aux avant-postes de la recherche pour un vaccin - Le Soir
Jean-Paul PRIEELS | Ceo | Research profile
Jean-Paul Prieels - Independent Director at Bone Therapeutics | The Org
Breakthrough Partnership Paves the Way for Advanced Exosome-Based Therapies----Shenzhen Institute of Advanced Technology
Dr. Jean-Paul PRIEELS | PDC*line Pharma
Démissions en masse à la tête de la biotech Promethera | L'Echo
Supervisory Board | Leukocare
Our Team - Quantoom Biosciences
Jean-Paul PRIEELS | Ceo | Research profile
MinervaX provides clinical and leadership update
Jean-Paul Prieels, l'ange gardien des biotechs | L'Echo
中科佰乘出访比利时，先进生物制造技术加速药物研发生产-中科佰乘（深圳）生物科技有限公司
Supervisory Board | Leukocare
News from Aduro, Catalent, and Eleven – People on the move
Jean-Paul Prieels - Chief Executive Officer - convEyXO | LinkedIn
PDF) Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease | Jean-Paul Prieels - Academia.edu
